Position in NBIX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$512,863
+$78,155 QoQ
Shares Held
3,893
+27.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ROTHSCHILD INVESTMENT LLC holds $1,834,012 across 42 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (28.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
3,893 | $512,863 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
17,216 | $318,840 | |
| 3 | ZTS |
Zoetis Inc.
|
2,182 | $257,934 | |
| 4 | VTRS |
Viatris Inc
|
17,709 | $239,248 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
347 | $205,764 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,452 | $73,854 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
1,040 | $57,522 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
4,266 | $53,026 |
All Filings in NBIX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $512,863 | 3,893 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $434,708 | 3,065 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $388,150 | 2,765 | Shares | Sole | 2025-11-07 | |
| 2025-03-31 | $331 | 3 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $409 | 3 | Shares | Sole | 2025-02-04 | |
| No filing history on record for this holder in this stock. | ||||||